Top Markets
Coin of the day
Lakewood-Amedex Biotherapeutics Inc. Common Stock Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT
Rank in Stocks #35448
This biopharmaceutical company is dedicated to developing innovative... This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
Share Price
$2.23
Last synced: 2026-08-14
Market Cap
$3.90M
Change (1 day)
-4.48%
Change (1 year)
-
Country
US
Trade Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)

Category

P/S ratio for Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)
P/S ratio as of 2026 TTM: 0
According to Lakewood-Amedex Biotherapeutics Inc. Common Stock latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Lakewood-Amedex Biotherapeutics Inc. Common Stock from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE